Related Experiment Video
Updated: Aug 7, 2025

Author Spotlight: Advancing Research on Candida albicans Biofilm-Associated Prosthetic Joint Infections
Published on: February 2, 2024
Promising applications of D-amino acids in periprosthetic joint infection
Matthew Caldwell1, Megan Hughes2, Fei Wei1
1Biionix Cluster & College of Medicine, University of Central Florida, 6900 Lake Nona Blvd, Orlando, FL, 32827, USA.
Insights
Dextrorotatory-isoforms of amino acids (D-AAs) show promise in combating periprosthetic joint infections (PJIs) by disrupting bacterial biofilms. Further research into D-AA bioengineering could lead to novel prevention and treatment strategies for PJIs following total joint arthroplasty.
Area of Science:
- Biomedical Engineering
- Infectious Diseases
- Orthopedic Surgery
Background:
- Aging populations are increasing demand for total joint arthroplasty (TJA), leading to a projected rise in periprosthetic joint infections (PJIs).
- Microbial biofilm formation presents a significant challenge in preventing and treating PJIs, despite advancements in surgical protocols.
- Dextrorotatory-isoforms of amino acids (D-AAs) are crucial for bacterial cell wall integrity and have demonstrated antimicrobial properties.
Purpose of the Study:
- To review the emerging role of D-AAs in the context of total joint arthroplasty (TJA).
- To explore the potential of D-AAs in preventing and treating periprosthetic joint infections (PJIs) by targeting biofilms.
- To highlight D-AAs as novel therapeutic targets for PJI management.
Main Methods:
- Literature review examining existing data on D-AAs and their effects on bacterial biofilms.
- Analysis of D-AA properties relevant to bacterial adhesion, biofilm formation, and disassembly.
- Exploration of D-AA's potential impact on host bone tissue response in the context of TJA.
Main Results:
- Exogenous administration of D-AAs has shown efficacy in preventing bacterial adhesion and biofilm formation on abiotic surfaces.
- D-AAs demonstrate substantial potential in promoting the disassembly of established microbial biofilms.
- The specific role of D-AAs in disrupting PJI biofilms and influencing host bone tissue response requires further investigation.
Conclusions:
- D-AAs represent a promising novel strategy for combating bacterial biofilms associated with periprosthetic joint infections (PJIs).
- D-AA bioengineering may offer a future therapeutic approach for the prevention and treatment of PJIs after total joint arthroplasty (TJA).
- Further research is warranted to fully elucidate the mechanisms and applications of D-AAs in PJI management.
Abstract:
Due to the rise in our aging population, a disproportionate demand for total joint arthroplasty (TJA) in the elderly is forecast. Periprosthetic joint infection (PJI) represents one of the most challenging complications that can occur following TJA, and as the number of primary and revision TJAs continues to rise, an increasing PJI burden is projected. Despite advances in operating room sterility, antiseptic protocols, and surgical techniques, approaches to prevent and treat PJI remain difficult, primarily due to the formation of microbial biofilms. This difficulty motivates researchers to continue searching for an effective antimicrobial strategy. The dextrorotatory-isoforms of amino acids (D-AAs) are essential components of peptidoglycan within the bacterial cell wall, providing strength and structural integrity in a diverse range of species. Among many tasks, D-AAs regulate cell morphology, spore germination, and bacterial survival, evasion, subversion, and adhesion in the host immune system. When administered exogenously, accumulating data have demonstrated that D-AAs play a pivotal role against bacterial adhesion to abiotic surfaces and subsequent biofilm formation; furthermore, D-AAs have substantial efficacy in promoting biofilm disassembly. This presents D-AAs as promising and novel targets for future therapeutic approaches. Despite their emerging antibacterial efficacy, their role in disrupting PJI biofilm formation, the disassembly of established TJA biofilm, and the host bone tissue response remains largely unexplored. This review aims to examine the role of D-AAs in the context of TJAs. Data to date suggest that D-AA bioengineering may serve as a promising future strategy in the prevention and treatment of PJI.
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Peptidoglycan Synthesis

